THIS IS A REQUEST FOR INFORMATION PURPOSES ONLY, NOT A REQUEST FOR QUOTE OR SOLICITATION. The Food and Drug Administration, Jefferson Laboratories, in Jefferson, Arkansas, is seeking business sources, including small business concerns, service-disabled veteran-owned small businesses, HUBZone small businesses, and 8(a) certified companies. The following information is provided to assist the FDA in conducting Market Research to identify potential contractors for this effort:

The government is seeking capability statements from companies capable of publishing and distributing peer reviewed manuscripts from the Microarray Quality Control (MAQC) phase II project. The goal of the project is to develop best practices in genomics and bioinformatics for predictive and personalized medicine. The successful vendor must have a high-quality, peer-reviewed scientific publication program. The FDA requires the vendor to have a highly respected scientific journal, go through the peer-review process and publish the results. Interested vendors must show their experience with the publishing of scientific journals relating to biotechnology. Publication readership and experience will be considered that will have the most impact on the scientific and regulatory communities.

The associated North American Industry Classification System (NAICS) Code is-511120- Periodical Publishers; Small Business Size Standard is 500 employees.

Potential contractors must indicate business size, proof of any set-aside certification and company's DUNS number and provide a contact name, the mailing address, phone number and email address of point of contact. Capability statements must provide enough information to determine if the company can meet the requirement. At a minimum provide the following:
Reference similar work that has been performed by the contractor in the last three (3) years, a description of the work performed and contact information for references knowledgeable about the quality of the work completed.

Interested Contractors must respond with capability statements which are due in person, by postal mail, fax or email to the point of contact listed below on or before September 2, 2009 by 13:00 hours (Central Time in Jefferson, Arkansas) at the Food and Drug Administration, OC/OSS/OFFAS, Attn: Nick Sartain, 3900 NCTR Road, HFT-320, and Jefferson, AR 72079-9502. Reference solicitation number FDA1062304.

For information regarding this request for information, please contact Nick Sartain at (870) 543-7370, FAX (870) 543-7990 or email [email protected].

Disclaimer and Important Notes.
This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation.

Confidentiality. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s)."